Antibody Machine Learning Graduate Student Internship jobs in United States
cer-icon
Apply on Employer Site
company-logo

Adimab · 1 week ago

Antibody Machine Learning Graduate Student Internship

Adimab is the leading technology provider for therapeutic antibody drug discovery, focusing solely on partnerships without pursuing an internal product pipeline. They are seeking a graduate student intern to contribute to projects aimed at generating de novo antibody designs and machine learning-based predictions of developability properties.

BiotechnologyCollaborationHealth CareTherapeutics
check
Comp. & Benefits
check
H1B Sponsor Likelynote

Responsibilities

Generate de novo antibody designs using applicable computational methods
Work with experimental groups to test predictions and use their feedback to refine the design process

Qualification

Antibody structure predictionComputational binder designAlphaFoldPythonTensorFlowPyTorchSilico methodsResearch publicationsPresentation skills

Required

Experience in antibody:antigen structure prediction, computational binder design, or in silico methods for distinguishing native protein:protein interfaces, demonstrated through thesis work, presentations, preprints, or publications
Hands-on experience with AlphaFold, ProteinMPNN, and similar tools; proficient in Python, Tensorflow, and PyTorch
The ideal candidate has passed their PhD qualifiers and is 3-4 years into the program

Benefits

Relocation assistance

Company

Adimab

twittertwitter
company-logo
Adimab is an antibody discovery and optimization platform, developing full-length human Immunoglobulin Gs.

H1B Sponsorship

Adimab has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (2)
2024 (2)
2023 (1)
2022 (1)
2021 (3)
2020 (1)

Funding

Current Stage
Late Stage
Total Funding
$45.48M
Key Investors
Google Ventures
2020-01-01Series Unknown
2012-04-02Series F· $14M
2010-12-01Series E· $4M

Leadership Team

leader-logo
Philip Chase
Chief Executive Officer
linkedin
leader-logo
Max Vasquez
VP Computational Biology
linkedin
Company data provided by crunchbase